cro.directory
← Compare landing

Clarenta vs Linical

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/comac-medical/linical

CategoryClarentaLinical
Listed sitecrocro
SummaryClarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.Global, award-winning CRO guiding clinical development from early-phase research to large-scale global studies with 90% client retention.
Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
  • Pharmacovigilance & Drug Safety
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • Medical Writing
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Trial Services
  • Pharmacovigilance & Drug Safety
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Oncology
  • Rare Disease
  • Neurology
  • Psychiatry
  • Respiratory
  • Dermatology
  • Gastroenterology
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
Locations
  • Sofia, Sofia, Bulgaria
  • Paris, Paris, France
  • London, London, United Kingdom
  • Germany, Germany
  • North Macedonia, North Macedonia
  • Georgia, Georgia
  • Poland, Poland
  • Romania, Romania
  • Turkey, Turkey
  • United States (business development), United States
  • Global Operations
  • Japan, Japan, Japan
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.